Point-of-Care Testing in Diabetes Care

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 2, 2011, Pages 178-184

  Matteucci, E ^a   Giampietro, O ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Blood glucose self monitoring; Diabetes mellitus; HbA1c; Ketones; Lipids; Point of care systems; Quality control; Urinary albumin

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ALBUMIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KETONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANALYTICAL ERROR; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CAPILLARY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DECISION MAKING; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIET RESTRICTION; GLYCEMIC CONTROL; HUMAN; KETOACIDOSIS; LONG TERM CARE; PHYSICIAN; POINT OF CARE TESTING; PREDICTION; QUANTITATIVE ANALYSIS; RELIABILITY; RISK FACTOR; SELF CARE; URINALYSIS; VALIDITY;

ALBUMINURIA; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HUMANS; POINT-OF-CARE SYSTEMS;

EID: 79951684274     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955711794519474     Document Type: Article

References (50)

1. Ehrmeyer, S.S.; Laessig, R.H. Point-of-care testing, medical error, and patient safety: a 2007 assessment. Clin. Chem. Lab. Med., 2007, 45, 766-73.
2. Kost, G.J.; Louie, R.F.; Tang, Z.; Lee, J.H.; Somsanith, K.J.; Tran, N.K. Reducing potential medical errors in point-ofcare testing. Clinical effects of heparin and EDTA on handled glucose meter results. Point Care. 2002, 1, 2-8.
3. Meier, F.A.; Jones, B.A. Point-of-care testing error: sources andamplifiers, taxonomy, prevention strategies, and detection monitors. Arch. Pathol. Lab. Med., 2005, 129, 1262-7.
4. Nichols, J.H.; Christenson, R.H.; Clarke, W.; Gronowski, A.; Hammett-Stabler, C.A.; Jacobs, E.; Kazmierczak, S.; Lewandrowski, K.; Price, C.; Sacks, D.B.; Sautter, R.L.; Shipp, G.; Sokoll, L.; Watson, I.D.; Winter, W.; Zucker, M.L.; NationalAcademy of Clinical Biochemistry. Executive summary. The NationalAcademy of Clinical Biochemistry Laboratory MedicinePractice Guideline: evidence-based practice for point-of-care testing. Clin. Chim. Acta, 2007, 379, 14-28.
5. Sautter, R.L.; Lipford, E.H. Point-of-Care testing: guidelines andchallenges. N.C. Med. J., 2007, 68, 132-5.
6. Price, C.P. Point of care testing. Br. Med. J., 2001, 322, 1285-8.
7. Ryan, R.J.; Lindsell, C.J.; Hollander, J.E.; O'Neil, B.; Jackson, R.; Schreiber, D.; Christenson, R.; Gibler, W.B. A multicenter randomizedcontrolled trial comparing central laboratory and point-of-carecardiac marker testing strategies: the Disposition Impacted by SerialPoint of Care Markers in Acute Coronary Syndromes (DISPOACS)trial. Ann. Emerg. Med., 2009, 53, 321-8.
8. Grieve, R.; Beech, R.; Vincent, J.; Mazurkiewicz, J. Near patienttesting in diabetes clinics: appraising the costs and outcomes. Health Technol. Assess., 1999, 3, 1-74.
9. Parry, D.; Fitzmaurice, D.; Raftery, J. Anticoagulation managementin primary care: a trial-based economic evaluation. Br. J. Haematol., 2000, 111, 530-3.
10. Laurence, C.; Gialamas, A.; Yelland, L.; Bubner, T.; Ryan, P.; Willson, K.; Glastonbury, B.; Gill, J.; Shephard, M.; Beilby, J. formembers of the PoCT Trial Management Committee. A pragmaticcluster randomised controlled trial to evaluate the safety, clinicaleffectiveness, cost effectiveness and satisfaction with point of caretesting in a general practice setting -rationale, design and baselinecharacteristics. Trials, 2008, 9, 50.
11. Bamberg, R.; Schulman, K.; MacKenzie, M.; Moore, J.; Olchesky, S. Effect of adverse storage conditions on performance of glucometertest strips. Clin. Lab. Sci., 2005, 18, 203-9.
12. Kristensen, G.B.B.; Christensen, N.G.; Thue, G.; Sandberg, S. Between-lot variation in external quality assessment of glucose:clinical importance and effect on participant performance evaluation. Clin. Chem., 2005, 51, 1632-6.
13. Shephard M.D.; Mazzachi, B.C.; Shephard, A.K.; McLaughlin, K.J.; Denner, B.; Barnes, G. The impact of point of care testing ondiabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program. Rural Remote Health., 2005, 5, 371.
14. Cagliero, E.; Levina, E.V.; Nathan, D.M. Immediate feedback ofHbA1c levels improves glycemic control in type 1 and insulintreatedtype 2 diabetic patients. Diabetes Care, 1999, 22, 1785-9.
15. Petersen, J.R.; Finley, J.B.; Okorodudu, A.O.; Mohammad, A.A.; Grady, J.J.; Bajaj, M. Effect of point-of-care on maintenance ofglycemic control as measured by A1C. Diabetes. Care, 2007, 30, 713-5.
16. Rink, E.; Hilton, S.; Szczepura, A.; Fletcher, J.; Sibbald, B.; Davies, C.; Freeling, P.; Stilwell, J. Impact of introducing near patienttesting for standard investigations in general practice. Br. Med. J, 1993, 307, 775-8.
17. Fitzmaurice, D.A.; Hobbs, F.D.R.; Murray, E.T.; Holder, R.L.; Allan, T.F.; Rose, P.E. Oral anticoagulation management in primarycare with the use of computerized decision support and nearpatienttesting: a randomized, controlled trial. Arch. Int. Med., 2000, 160, 2343-8.
18. Fitzmaurice, D.A.; Murray, E.T.; Allan, T.F.; Holder, R.L.; Hobbs, F.D.R.; Rose, P.E.; Hobbs, F.D.R. A comparison of internationalnormalised ratio (INR) measurement in hospital and general practicesettings: evidence for lack of standardisation. J. Clin. Pathol., 2000, 53, 803-6.
19. Krentz, A.J.; Olufadi, R.; Byrne, C.D. In Point of care testing, second edition; Price C.P.; St. John, A.; Hicks, J.M., Eds.; AACCPress: Washington, D.C., 1999; pp. 309-22.
20. Brown, J.B.; Harris, S.B.; Webster-Bogaert, S. Point-of-Care Testingin Diabetes Management: What Role Does It Play? DiabetesSpectrum, 2004, 17, 244-8.
21. American Diabetes Association. Standards of medical care indiabetes. Diabetes Care, 2011, 34, S11-S61.
22. Sacks, D.B.; Bruns, D.E.; Goldstein, D.E.; Maclaren, N.K.; McDonald, J.M.; Parrott, M. Guidelines and recommendations forlaboratory analysis in the diagnosis and management of diabetesmellitus. Clin. Chem., 2002, 48, 436-72.
23. Karon, B.S.; Griesmann, L.; Scott, R.; Bryant, S.C.; Dubois, J.A.; Shirey, T.L.; Presti. S.; Santrach, P.J. Evaluation of the impact ofhematocrit and other interference on the accuracy of hospital-basedglucose meters. Diabetes Technol. Ther., 2008, 10, 111-20.
24. Solnica, B.; Naskalski, J.; Gernand, W. Analytical evaluation of theOptium Xido blood glucose meter. Clin. Chem. Lab. Med., 2008, 46, 143-7.
25. Weitgasser, R.; Hofmann, M.; Gappmayer, B.; Garstenauer, C. New, small, fast acting blood glucose meters--an analytical laboratoryevaluation. Swiss Med. Wkly., 2007, 137, 536-40.
26. Diabetes Research in Children Network (DirecNet) Study Group. Relative accuracy of the BD Logic and FreeStyle blood glucosemeters. Diab. Technol. Ther., 2007, 9, 165-8.
27. Bilen, H.; Kilicaslan, A.; Akcay, G.; Albayrak, F. Performance ofglucose dehydrogenase (GDH) based and glucose oxidase (GOX)based blood glucose meter systems at moderately high altitude. J. Med. Eng. Technol., 2007, 31, 152-6.
28. Arabadjief, D.; Nichols, J.H. Assessing glucose meter accuracy. Curr. Med. Res. Opin., 2006, 22, 2167-74.
29. Chen, E.T.; Nichols, J.H.; Duh, S.H.; Hortin, G. Performanceevaluation of blood glucose monitoring devices. Diabetes Technol. Ther., 2003, 5, 749-68.
30. Fink, K.S.; Christensen, D.B.; Ellsworth, A. Effect of high altitudeon blood glucose meter performance. Diabetes Technol. Ther., 2002, 4, 627-35.
31. Skeie, S.; Thue, G.; Nerhus, K.; Sandberg, S. Instruments for selfmonitoringof blood glucose: comparisons of testing qualityachieved by patients and a technician. Clin. Chem., 2002, 48, 994-1003.
32. Tura, A. Noninvasive glycaemia monitoring: background, traditionalfindings, and novelties in the recent clinical trials. Curr. Opin. Clin. Nutr. Metab. Care., 2008, 11, 607-12.
33. Shephard, M.D.; Gill, J.P. The Analytical Quality of Point-of-CareTesting in the 'QAAMS' Model for Diabetes Management in AustralianAboriginal Medical Services. Clin. Biochem. Rev., 2006, 27, 185-90.
34. Kennedy, L.; Herman, W.H.; GOAL A1C Study Team. Glycatedhemoglobin assessment in clinical practice: comparison of theA1cNow point-of-care device with central laboratory testing(GOAL A1C Study). Diabetes Technol. Ther., 2005, 7, 907-12.
35. Stivers, C.R.; Baddam, S.R.; Clark, A.L.; Ammirati, E.B.; Irvin, B.R.; Blatt, J.M. A miniaturized self-contained single-use disposablequantitatitve test for hemoglobin A1c in blood at the point ofcare. Diabetes Technol. Ther., 2000, 2, 51726.
36. Guerci, B.; Tubiana-Rufi, N.; Bauduceau, B.; Bresson, R.; Cuperlier, A.; Delcroix, C.; Durain, D.; Fermon, C.; Le Floch, J.P.; LeDevehat, C.; Melki, V.; Monnier, L.; Mosnier-Pudar, H.; Taboulet, P.; Hanaire-Broutin, H. Advantages to using capillary blood betahydroxybutyratedetermination for the detection and treatment ofdiabetic ketosis. Diabetes Metab., 2005, 31, 401-6.
37. Wallace, T.M.; Matthews, T.R. Recent advances in the monitoringand management of diabetic ketoacidosis. Q. J. Med., 2004, 97, 773-80.
38. Byrne, H.A.; Tieszen, K.L.; Hollis, S.; Dornan, T.L.; New, J.P. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care, 2000, 23, 500-3.
39. Tantiwong, P.; Puavilai, G.; Ongphiphadhanakul, B.; Bunnag, P.; Ngarmukos, C. Capillary blood beta-hydroxybutyrate measurementby reagent strip in diagnosing diabetic ketoacidosis. Clin. Lab. Sci., 2005, 18, 139-44.
40. National Cholesterol Education Program. Recommendations onlipoprotein measurement. NIH Publication No. 953044, 1995.
41. Singh, S.; Chaubey, A.; Malhotra, B.D. Amperometric cholesterolbiosensor based on immobilized cholesterol esterase on conductingpolypyrrole films. Anal. Chim. Acta, 2004, 502, 229-34.
42. Yamada, T.; Nishino, S.; Takubo, T.; Hino, M.; Kitagawa, S.; Tatsumi, N. Simple high-density lipoprotein cholesterol assaybased on dry chemistry. Clin. Chim. Acta, 2002, 320, 78-88.
43. Okada, M.; Matsui, H.; Ito, Y.; Fujiwara, A.; Inano, K. Lowdensitylipoprotein cholesterol can be chemically measured: a newsuperior method. J. Lab. Clin. Med., 1998, 132, 195-201.
44. Stein, J.H.; Carlsson, C.M.; Papcke-Benson, K.; Einerson, J.A.; McBride, P.E.; Wiebe, D.A. Inaccuracy of lipid measurements withthe portable Cholestech L.D. X analyzer in patients with hypercholesterolemia. Clin Chem., 2002, 48, 284-90.
45. Taylor, J.R.; Lopez, L.M. Cholesterol: point-of-care testing. Ann. Pharmacother., 2004, 38, 1252-7.
46. Bowden, R.G.; Kingery, P.M., Long, L. Precision of a drychemistrymethod of lipid screening. Public Health., 2006, 120, 572-6.
47. Shephard M.D.; Mazzachi, B.C.; Shephard, A.K. Comparativeperformance of two point-of-care analysers for lipid testing. Clin. Lab., 2007, 53, 561-6.
48. Sarafidis, P.A.; Riehle, J.; Bogojevic, Z.; Basta, E.; Chugh, A.; Bakris, G.L. A comparative evaluation of various methods for microalbuminuriascreening. Am. J. Nephrol., 2008, 28, 324-9.
49. Le Floch, J.P.; Marre, M.; Rodier, M.; Passa, P.H. Interest ofClinitek Microalbumin in screening for microalbuminuria: resultsof a multicentre study in 302 diabetic patients. Diabetes Metab., 2001, 27, 36-9.
50. Parikh, C.R.; Fischer, M.J.; Estacio, R.; Schrier, R.W. Rapid microalbuminuriascreening in type 2 diabetes mellitus: simplifiedapproach with Micral test strips and specific gravity. Nephrol. Dial. Transplant., 2004, 19, 1881-5.